The chain patented new tech to help better manage oncolytic usage.
New plans are designed around feedback and a desire to increase safety checks.
The last 12 drugs approved in the year, along with the other 34.
We asked pharmacists from all over the country what resolutions pharmacists should make in 2018. Here's what they said.
Our 10 best articles, based on the number of views.
The CVS/Aetna deal won’t kill traditional pharmacy—it just shows that it’s already dead.
Now that an official proposal has been announced, how are industry leaders responding?
Samples of the diabetes medication were contaminated.
Don’t know what to get your coworkers? Relax, we’ve got you covered.
Even if it doesn't happen, the deal says a lot about the current and future states of pharmacy.